Literature DB >> 1666124

Peripheral neuropathy in patients with beta-thalassaemia.

D A Papanastasiou1, D Papanicolaou, A M Magiakou, N G Beratis, E Tzebelikos, T Papapetropoulos.   

Abstract

As some patients with beta-thalassaemia manifested neurological signs, clinical and electrophysiological investigations were carried out on 53 thalassaemic patients and 29 healthy control subjects. Twenty per cent of the patients showed clinical and electrophysiological findings of a mild peripheral sensorimotor neuropathy, mainly of the lower limbs. The clinical symptoms were numbness, pins and needles sensations, muscular cramps, myalgia and muscle weakness. The electrophysiological abnormalities were manifested by decreased motor conduction velocity (MCV) and prolonged F-wave latencies of the tibial and the peroneal nerves. Borderline increase in the latencies of the sensory potentials of the median nerve was also observed. The electromyographic findings of the patients with diminished MCVs were compatible with a predominantly motor peripheral neuropathy. This neuropathy appears during the second and third decade of life.

Entities:  

Mesh:

Year:  1991        PMID: 1666124      PMCID: PMC1014624          DOI: 10.1136/jnnp.54.11.997

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

1.  E.N.T. complications in thalassaemia major.

Authors:  J W Hazell; C B Modell
Journal:  J Laryngol Otol       Date:  1976-09       Impact factor: 1.469

2.  Beneficial effects of transfusing a patient with nontransfusion-dependent thalassaemia major.

Authors:  N McIntosh
Journal:  Arch Dis Child       Date:  1976-06       Impact factor: 3.791

3.  Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects.

Authors:  J Logothetis; M Constantoulakis; J Economidou; C Stefanis; P Hakas; O Augoustaki; K Sofroniadou; R Loewenson; M Bilek
Journal:  Neurology       Date:  1972-03       Impact factor: 9.910

4.  Iron absorption and loading in beta-thalassaemia intermedia.

Authors:  M J Pippard; S T Callender; G T Warner; D J Weatherall
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

5.  Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria.

Authors:  R M Bannerman; G Keusch; M Kreimer-Birnbaum; V K Vance; S Vaughan
Journal:  Am J Med       Date:  1967-03       Impact factor: 4.965

6.  Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.

Authors:  N F Olivieri; J R Buncic; E Chew; T Gallant; R V Harrison; N Keenan; W Logan; D Mitchell; G Ricci; B Skarf
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

7.  Neurological complications of beta-thalassaemia major.

Authors:  D Sinniah; V Vignaendra; K Ahmad
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

  7 in total
  3 in total

1.  Peripheral Neuropathy in Thalassemia Major.

Authors:  Jaya Shankar Kaushik; Anjali Verma; Harshit Sharma; Kiran Bala; Surekha Dabla; Alka Yadav
Journal:  Indian J Pediatr       Date:  2018-10-17       Impact factor: 1.967

2.  Polyneuropathy Associated with Severe Iron Overload and Oxidative Stress in β-Thalassemia Patients.

Authors:  Mona H El-Tagui; Khaled M Salama; Mohamed H El-Sabbagh; Eman R Youness; Marwa Ragaey; Amina Abdel-Salam
Journal:  Indian J Hematol Blood Transfus       Date:  2018-11-22       Impact factor: 0.900

3.  Peripheral neuropathy in thalassaemia.

Authors:  Raja A Sawaya; Laila Zahed; Ali Taher
Journal:  Ann Saudi Med       Date:  2006 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.